USD 0.27
(0.33%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 97 Thousand USD | 10.84% |
2022 | 87.51 Thousand USD | -95.58% |
2021 | 1.98 Million USD | -48.45% |
2020 | 3.84 Million USD | 33.21% |
2019 | 2.88 Million USD | 417.95% |
2018 | 557 Thousand USD | 2831.58% |
2017 | 19 Thousand USD | -70.77% |
2016 | 65 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 8.56 Million USD | 0.0% |
2024 Q1 | 87 Thousand USD | 0.0% |
2023 Q1 | 88 Thousand USD | 0.56% |
2023 Q2 | 144 Thousand USD | 63.64% |
2023 Q3 | 121 Thousand USD | -15.97% |
2023 FY | 97 Thousand USD | 10.84% |
2023 Q4 | 97 Thousand USD | -19.83% |
2022 Q2 | 1.82 Million USD | -3.99% |
2022 FY | 87.51 Thousand USD | -95.58% |
2022 Q4 | 87.51 Thousand USD | -94.99% |
2022 Q3 | 1.74 Million USD | -4.49% |
2022 Q1 | 1.9 Million USD | -3.89% |
2021 Q1 | 3.52 Million USD | -8.38% |
2021 Q2 | 2.12 Million USD | -39.65% |
2021 Q3 | 2.05 Million USD | -3.34% |
2021 Q4 | 1.98 Million USD | -3.55% |
2021 FY | 1.98 Million USD | -48.45% |
2020 FY | 3.84 Million USD | 33.21% |
2020 Q4 | 3.84 Million USD | -8.96% |
2020 Q1 | 2.72 Million USD | -5.65% |
2020 Q3 | 4.22 Million USD | -7.37% |
2020 Q2 | 4.55 Million USD | 67.41% |
2019 Q1 | 3.45 Million USD | 520.29% |
2019 Q3 | 3.11 Million USD | -5.29% |
2019 Q4 | 2.88 Million USD | -7.47% |
2019 FY | 2.88 Million USD | 417.95% |
2019 Q2 | 3.29 Million USD | -4.72% |
2018 Q4 | 557 Thousand USD | 0.0% |
2018 Q3 | - USD | -100.0% |
2018 Q2 | 4000.00 USD | -60.0% |
2018 Q1 | 10 Thousand USD | -47.37% |
2018 FY | 557 Thousand USD | 2831.58% |
2017 Q4 | 19 Thousand USD | 0.0% |
2017 FY | 19 Thousand USD | -70.77% |
2016 FY | 65 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Perspective Therapeutics, Inc. | - USD | -Infinity% |
Electromed, Inc. | - USD | -Infinity% |
Senseonics Holdings, Inc. | 41.19 Million USD | 99.765% |
Xtant Medical Holdings, Inc. | 17.16 Million USD | 99.435% |